Company profile
Sanara MedTech Inc.
NASDAQ: SMTI · Healthcare · Medical - Instruments & Supplies
#347 of 1,418 Healthcare companies by revenue65th-percentile growth
EA Score
61CFH 53DQ 65GM 70SS 77
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ return on equity, balance-sheet leverage
Methodology →Revenue TTM
$107.5M
Rev growth YoY (TTM)
+17.4%
Net income (FY)
-$37.6M
Employees
108
as of 2026-08-13
Market cap
$315.6M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$103.1M$103.1M2025
Net income-$37.6M-$37.6M2025
Operating income$7.3M$7.3M2025
Total assets$72.9M$72.9M2025
Liabilities$67.0M$67.0M2025
Equity$5.9M$5.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY20
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2023
By product
Royalty100%
By geography
Not disclosed.
The read
What is Sanara MedTech Inc.’s revenue?
Sanara MedTech Inc. booked $103.1M in FY2025 revenue, growing 19% year over year — faster than most Healthcare companies we track, at a -36.4% net margin.
Peers · Healthcare
Zymeworks Inc.55COwlet, Inc.49DPlanet 13 Holdings Inc.44DSutro Biopharma, Inc.47DViewRay, Inc.——StateHouse Holdings Inc.——Neighbors
Tarrant →Key facts
CEOSeth D. Yon
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersFort Worth, TX
ExchangeNASDAQ: SMTI
Employees108
IPO date1994-04-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.